Bivalirudin Appears To Be Effective In Treating Post-COVID-19 Vaccination Blood Clot Case, Researchers Say

MedPage Today (5/4, Phend) reports, “Bivalirudin (Angiomax) worked for one of the very rare cases of blood clots with low platelets after vaccination against COVID-19, researchers reported.” After receiving the treatment, the 40-year-old patient’s “platel...